AA
RVMD icon

Ancora Advisors’s Revolution Medicines RVMD Stock Holding History

Ancora Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Sell
20
-248
-93% -$36.2K ﹤0.01% 1675
2026
Q1 		$26.1K Buy
+268
New +$27.1K ﹤0.01% 1423
2021
Q3 		– Sell
-32
Closed -$1K – 2283
2021
Q2 		$1K Hold
32
– – ﹤0.01% 1895
2021
Q1 		$1K Hold
32
– – ﹤0.01% 1692
2020
Q4 		$1K Hold
32
– – ﹤0.01% 1427
2020
Q3 		$1K Hold
32
– – ﹤0.01% 1367
2020
Q2 		$1K Hold
32
– – ﹤0.01% 1312
2020
Q1 		$1K Buy
+32
New +$886 ﹤0.01% 1392

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ancora Advisors's RVMD Position: Q2 2026 in Review

Ancora Advisors reduced its Revolution Medicines (RVMD) stake by 93% in Q2 2026, selling an estimated $36.2K and leaving 20 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Ancora Advisors first reported a position in RVMD in Q1 2020 and has held it in 8 quarters since. The position peaked at $26.1K in Q1 2026. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Ancora Advisors held 20 shares of Revolution Medicines worth $3.75K as of Q2 2026.
  • Ancora Advisors sold 248 Revolution Medicines shares in Q2 2026, an estimated $36.2K.
  • Revolution Medicines made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1675 holding.
  • Ancora Advisors first reported a position in Revolution Medicines in Q1 2020 and has held it in 8 quarters since.
  • Ancora Advisors's Revolution Medicines position peaked at $26.1K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.